The Peptide Therapeutics Contract API Manufacturing Market Size is valued at USD 2.36 billion in 2023 and is predicted to reach USD 3.77 billion by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031.
Peptide therapeutics contract API manufacturing is a technique of extending the production of drugs with active pharmaceutical components (APIs) or the parts that provide an external entity with the desired results. The increasing need for peptide therapies to treat the rising incidence of aggressive cancer diseases globally has led businesses in the peptide therapeutics contract API manufacturing industry to increase their capacity for production. As part of their efforts to raise consciousness, they additionally collaborate with oncology institutions. Peptide therapeutics contract API manufacturing popularity has expanded due to preferences for peptide-based drugs. In order to enable more rapid and efficient APIs, a number of breakthroughs in technology are also being developed.
However, the challenges of complying with regulations are impeding the expansion of the Peptide Contract API production sector. Also, the main challenges in API peptide production are preserving the structural integrity of the molecules and ensuring accurate dosing. These biologics are highly sensitive and prone to degradation, which makes it challenging to formulate and deliver them effectively. Advancements in drug design have resulted in the creation of novel drug molecules in the form of API peptides. Due to their substantial therapeutic potential, market opportunities, and economic value, it is expected that therapeutic peptides will attract continued investment and research, driving long-term success.
The peptide therapeutics contract API manufacturing market is segmented based on scale of operation, type of synthesis method used, and enterprise type. Based on the scale of operation, the market is segmented into preclinical/clinical and commercial. By synthesis method used, the market is segmented into non-chemical synthesis method and chemical synthesis method. By enterprise type, the market is segmented into large enterprises and small and medium enterprises.
The small and medium enterprise peptide therapeutics contract API manufacturing market will hold a major global market share in 2023. Increasing recognition of the significance of data security and encryption has led smaller organizations to look for flexible, affordable solutions to protect their sensitive data from internet threats. The resources and expertise required to manage the institution's primary administrative processes properly often need to be improved in SMEs.
The chemical synthesis industry uses bulk peptide therapeutics contract API manufacturing because chemical synthesis allows researchers to produce new substances with special qualities. Chemical synthesis has also enabled the development of numerous commercially significant goods, such as pharmaceuticals, polymers, and high-quality majority chemicals, especially in countries like the US, Germany, the UK, China, and India.
The North American peptide therapeutics contract API manufacturing market is expected to register the highest market share in revenue in the near future. This can be attributed to the rise in the spending of big businesses. Additionally, it is anticipated that rising medical costs and greater awareness of cutting-edge peptide medicines will fuel the growth of the local peptide therapeutics contract API manufacturing business. In addition, Asia Pacific is projected to grow rapidly in the global peptide therapeutics contract API manufacturing industry because there is a steady presence of key players. Peptide therapies contract API manufacturing will grow in the region as a result of increased awareness of easily accessible peptide production methods and increased emphasis on introducing peptide drugs to the commercial sector.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.36 Bn |
|
Revenue Forecast In 2031 |
USD 3.77 Bn |
|
Growth Rate CAGR |
CAGR of 6.3% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Scale Of Operation, Type of Synthesis Method Used, And Enterprise Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Ambiopharm Inc, Auspep, Bachem Holding AG, BCN Peptides, Chinese Peptide Company, CordenPharma, CPC Scientific, Creative Peptides, CSBio, Hybio Pharmaceutical, Peptide Institute, Inc., PolyPeptide Group, ScinoPharm, and Senn Chemicals AG. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Peptide Therapeutics Contract API Manufacturing Market Snapshot
Chapter 4. Global Peptide Therapeutics Contract API Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Peptide Therapeutics Contract API Manufacturing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Peptide Therapeutics Contract API Manufacturing Industry Trends
Chapter 5. Peptide Therapeutics Contract API Manufacturing Market Segmentation 1: By Scale of Operation, Estimates & Trend Analysis
5.1. Market Share by Scale of Operation, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Scale of Operation:
5.2.1. Preclinical/Clinical
5.2.2. Commercial
Chapter 6. Peptide Therapeutics Contract API Manufacturing Market Segmentation 2: By Type of Synthesis Method Used, Estimates & Trend Analysis
6.1. Market Share by Type of Synthesis Method Used, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Synthesis Method Used:
6.2.1. Non-chemical Synthesis Method
6.2.2. Chemical Synthesis Method
Chapter 7. Peptide Therapeutics Contract API Manufacturing Market Segmentation 3: By Enterprise Type, Estimates & Trend Analysis
7.1. Market Share by Enterprise Type, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Enterprise Types:
7.2.1. Large Enterprise
7.2.2. Small and Medium Enterprise
Chapter 8. Peptide Therapeutics Contract API Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Peptide Therapeutics Contract API Manufacturing Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
8.2.3. North America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Synthesis Method Used, 2019-2031
8.2.4. North America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Type, 2019-2031
8.3. Europe
8.3.1. Europe Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
8.3.3. Europe Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Synthesis Method Used, 2019-2031
8.3.4. Europe Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Type, 2019-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
8.4.3. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts By Type of Synthesis Method Used, 2019-2031
8.4.4. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Type, 2019-2031
8.5. Latin America
8.5.1. Latin America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
8.5.3. Latin America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Synthesis Method Used, 2019-2031
8.5.4. Latin America Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Type, 2019-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2019-2031
8.6.3. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Synthesis Method Used, 2019-2031
8.6.4. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Type, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Ambiopharm Inc
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Auspep
9.2.3. Bachem Holding AG
9.2.4. BCN Peptides
9.2.5. Chinese Peptide Company
9.2.6. CordenPharma
9.2.7. CPC Scientific
9.2.8. Creative Peptides
9.2.9. CSBio
9.2.10. Hybio Pharmaceutical
9.2.11. Peptide Institute, Inc.
9.2.12. PolyPeptide Group
9.2.13. ScinoPharm
9.2.14. Senn Chemicals AG
9.2.15. Other Prominent Players
Peptide Therapeutics Contract API Manufacturing Market By Scale of Operation-
Peptide Therapeutics Contract API Manufacturing Market By Type of Synthesis Method Used-
Peptide Therapeutics Contract API Manufacturing Market By Enterprise Type-
Peptide Therapeutics Contract API Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
